Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
about
Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsHMGB1 mediates endogenous TLR2 activation and brain tumor regressionTreg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeuticsIdentification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.EGFR gene overexpression retained in an invasive xenograft model by solid orthotopic transplantation of human glioblastoma multiforme into nude mice.Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.Adenoviral-mediated gene transfer into the canine brain in vivo.Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms.Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology.Novel therapies for meningiomas.Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide.Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaBiologically targeted therapeutics in pediatric brain tumors.Turning the gene tap off; implications of regulating gene expression for cancer therapeutics.Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits.Emerging immunotherapies for glioblastomaRelease of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity.Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.Mutations of the human interferon alpha-2b gene in brain tumor patients exposed to different environmental conditions.Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells.
P2860
Q27014829-C46FBC45-E5E1-4BB9-BE3A-D5049721A40DQ27307459-DAB43307-C9CA-4FF9-9594-069F1DC61ECCQ33330270-CBE0AE54-4C88-489C-8E2E-4464A4C51F4AQ33877450-76A5289A-2947-405F-A010-9434BFE5FB2BQ33949865-82C3E438-BB34-4953-B542-4EEF7BE99C0CQ34012284-019A45CB-9364-4461-906D-8475E95E1A06Q34661966-D7682D59-F1E9-4ED5-8B70-B9B8F43D815CQ35118919-89C9F266-69DF-420A-BF90-C44D78E1F1B7Q35870480-582BA898-487D-49E2-BA66-C4F6115F37CEQ36172992-FE958885-BAB9-4746-9888-9B0CF7A52353Q36367568-13A33DD0-2853-4404-8C0D-ADD6EA298DE2Q36499222-FDCABF1C-29B4-464B-AE5C-669B9A5CA720Q36641500-6DD39994-0D3D-4180-96E3-91CA30731BC8Q36658322-2C1E075B-A609-4F16-97E3-0A27C68B2365Q36750581-AF5DA7C5-11CF-4B5B-8556-3CE934B08FEFQ36811505-3BA4F466-3E51-4DBC-85EF-8A56177C3053Q36844744-B53E2178-A133-4423-862F-17992CEADE6EQ36994041-9F232FA8-6E64-42ED-B1E6-DBCC2DA75A90Q36994063-5CE29DA2-4E48-445E-A8C9-7FF780210718Q37025105-799D46F3-66D2-4C12-A536-6876D8D02CE2Q37403279-0CDA742A-D0C9-43F8-BF65-772674AA271AQ37804933-6FDCAA99-E820-4A14-9E54-3143B802D906Q38402828-39753CBF-B03D-49F6-8A17-CFF22DE0EDC5Q42592309-C0510576-1399-4250-88B1-E4C7D6C8C802
P2860
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
@ast
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
@en
type
label
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
@ast
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
@en
prefLabel
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
@ast
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
@en
P2093
P2860
P1476
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors
@en
P2093
Gwendalyn D King
Kurt M Kroeger
Marianela Candolfi
Pedro R Lowenstein
Remy B Greeno
P2860
P304
P356
10.2174/156802605774370856
P577
2005-01-01T00:00:00Z